RecruitingPhase 1NCT03816345
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Sponsor: National Cancer Institute (NCI)
New Brunswick, NJ · +50 more sites
Multiple Sclerosis clinical trials in New Brunswick, NJ
3 recruiting multiple sclerosis studies with a site in New Brunswick, NJ.
All trials in New Brunswick, NJ · All Multiple Sclerosis trials
RecruitingPhase 3NCT06408259
Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
Sponsor: Bristol-Myers Squibb
New Brunswick, NJ · Teaneck, NJ · +10 more sites
RecruitingPhase 1 / Phase 2NCT06063850
AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy
Sponsor: UniQure Biopharma B.V.
Hackensack, NJ · New Brunswick, NJ · +16 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.